Begin main content

Call for Patient Input and Clinical Experts: glucagon

June 25, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name TBC Generic name glucagon Manufacturer Eli Lilly Canada Inc. Indication(s) Severe hypoglycemic reactions Project Number SR0626-000 Call for patient input 2019-06-25 Patient input d...

New at CADTH - June 2019

June 13, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

The Path Forward for Integrating Key Functions of the Cancer Drug Implementation Advisory Committee (CDIAC) Into CADTH’s pan-Canadian Oncology Drug Review (pCODR) Process

June 12, 2019
We are pleased to announce that process and operational changes have been made to transition Cancer Drug Implementation Advisory Committee (CDIAC) functions to CADTH effective July 1, 2019.  These changes will further enhance the transparency of the CADTH pan-Canadian Oncology Drug Review (pCODR) review process and better support public pay...

Call for Patient Input and Clinical Experts: Ilumya

June 11, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Ilumya Generic name tildrakizumab Manufacturer Sun Pharma Canada Indication(s) Psoriasis, moderate to severe plaque Project Number SR0624-000 Call for patient input 2019-06-11 Pati...

Call for Patient Input and Clinical Experts: upadacitinib

May 31, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name TBC Generic name upadacitinib Manufacturer AbbVie Indication(s) Arthritis, Rheumatoid Project Number SR0614-000 Call for patient input 2019-05-31 Patient input deadline 2019-07-...